IN RE GENERIC PHARMACEUTICALS PRICING ANTITRUST

MDL 2724 16-MD-2724 16-CB-27240, 16-CB-27241, 16-CB-27242, 16-CB-27243 16-DG-27240, 16-DG-27241, 16-DG-27242, 16-DG-27243 16-DV-27240, 16-DV-27241, 16-DV-27242, 16-DV-27243 16-DX-27240, 16-DV-27241, 16-DX-27242, 16-DX-27243 16-EC-27240, 16-EC-27241, 16-EC-27242, 16-EC-27243 16-PV-27240, 16-PV-27241, 16-PV-27242, 16-PV-27243.

338 F.Supp.3d 404 (2018)

IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION. This Document Relates To: In re: Clobetasol Cases All Direct Purchaser, End-Payer, and Indirect Reseller Actions. In re: Digoxin Cases All Direct Purchaser, End-Payer, and Indirect Reseller Actions. In re: Divalproex ER Cases All Direct Purchaser, End-Payer, and Indirect Reseller Actions. In re: Doxycycline Cases All Direct Purchaser, End-Payer, and Indirect Reseller Actions. In re: Econazole Cases All Direct Purchaser, End-Payer, and Indirect Reseller Actions. In re: Pravastatin Cases All Direct Purchaser, End-Payer, and Indirect Reseller Actions.

United States District Court, E.D. Pennsylvania.

Signed October 16, 2018.

Editors Note
Applicable Law: 15 U.S.C. § 1
Cause: 15 U.S.C. § 1 Antitrust Litigation
Nature of Suit: 410 Other Statutes: Anti - Trust
Source: PACER


Attorney(s) appearing for the Case

DEFENSE LIAISON COUNSEL, IN RE, represented by CHUL PAK , WILSON SONSINI GOODRICH & ROSATI PC, JAN P. LEVINE , PEPPER HAMILTON LLP, LAURA S. SHORES , ARNOLD & PORTER KAYE SCHOLER LLP, SAUL P. MORGENSTERN , ARNOLD & PORTER KAYE SCHOLER LLP, SHERON KORPUS , KASOWITZ BENSON TORRES LLP, DAVID F. SORENSEN , BERGER MONTAGUE PC, DIANNE M. NAST , NASTLAW LLC, LINDA P. NUSSBAUM , NUSSBAUM LAW GROUP PC, MICHAEL L. ROBERTS , ROBERTS LAW FIRM, ROBERT N. KAPLAN , KAPLAN FOX & KILSHEIMER, LLP, THOMAS M. SOBOL , HAGENS BERMAN SOBOL SHAPIRO LLP, CANDICE ENDERS , BERGER MONTAGUE PC & ROBERTA D. LIEBENBERG , FINE, KAPLAN AND BLACK.

END-PAYER PLAINTIFFS PSC, IN RE, represented by ADAM J. ZAPALA , COTCHETT PITRE & MCCARTHY LLP, BONNY SWEENEY , HAUSFELD LLP, DENA C. SHARP , GIRARD SHARP LLP, ELIZABETH JOAN CABRASER , LIEFF, CABRASER, HEIMANN & BERNSTEIN, LLP, GREGORY S. ASCIOLLA , LABATON SUCHAROW LLP, HEIDI M. SILTON , LOCKRIDGE GRINDAL NAUEN PLLP, JAMES R. DUGAN, II , THE DUGAN LAW FIRM, JAYNE A. GOLDSTEIN , SHEPHERD FINKELMAN MILLER & SHAH LLP, JOSEPH R. SAVERI , JOSEPH SAVERI LAW FIRM, MICHAEL M. BUCHMAN , MOTLEY RICE LLC, MINDEE J. REUBEN , LITE DEPALMA GREENBERG LLC & ROBERTA D. LIEBENBERG , FINE, KAPLAN AND BLACK.

INDIRECT RESELLERS PSC, IN RE, represented by DANIEL S. MASON , FURTH SALEM MASON & LI LLP, DON BARRETT , BARRETT LAW OFFICES, ELIZABETH TIPPING , NEAL & HARWELL, PLC, FRANCIS O. SCARPULLA , LAW OFFICES OF FRANCIS O. SCARPULLA, JONATHAN W. CUNEO , CUNEO GILBERT & LADUCA LLP & ROBERTA D. LIEBENBERG , FINE, KAPLAN AND BLACK.

STATE ATTORNEYS GENERAL PLAINTIFFS, IN RE, represented by W. JOSEPH NIELSEN , ATTORNEY GENERAL'S OFFICE, ABIGAIL U. WOOD , PA OFFICE OF ATTORNEY GENERAL, CHERYL FAYE HIEMSTRA , OREGON DEPT OF JUSTICE, EMILY GRANRUD , NYS OFFICE OF ATTORNEY GENERAL, JULIA C. METZGER , STATE OF ALASKA OFFICE ATTORNEY GENERAL, LAURA JOHNSON MARTELLA , ATTORNEY GENERAL'S OFFICE, MARGARET PATON WALSH , ALASKA DEPARTMENT OF LAW, MAX M. MILLER , OFFICE OF THE ATTORNEY GENERAL OF IOWA, ROBERT L. HUBBARD , ATTORNEY GENERAL OF NEW YORK, ROBERTA D. LIEBENBERG , FINE, KAPLAN AND BLACK, SCHONETTE J. WALKER , MD OFFICE OF THE ATTORNEY GENERAL & TIMOTHY M. FRASER , FL OFFICE OF THE ATTORNEY GENERAL.

DAVID H. MARION, Special Master, pro se.

BRUCE P. MERENSTEIN, Special Master, pro se.

LINDA D. PERKINS, Special Master, pro se.

UNITED STATES OF AMERICA, Intervenor, represented by ANDREW J. EWALT , U.S. DEPT OF JUSTICE, ELLEN R. CLARKE , U.S. DEPT OF JUSTICE, JAY OWEN , U.S. DEPT OF JUSTICE - ANTITRUST DIV, JOSEPH C. FOLIO, III , U.S. DEPT OF JUSTICE, NATHAN D. BRENNER , U.S. DEPARTMENT OF JUSTICE, ANTITRUST DIVISION & RYAN J. DANKS , U.S. DEPARTMENT OF JUSTICE ANTITTRUST DIVISION.


OPINION

This multidistrict antitrust litigation alleges that certain pharmaceutical companies engaged in an unlawful scheme or schemes to fix, maintain and stabilize prices, rig bids, and engage in market and customer allocations of certain generic pharmaceutical products. In this Opinion, the...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases